NCT03971279View on ClinicalTrials.gov

Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2019

Conditions
Posterior Uveitis
Interventions
DRUG

Dexamethasone Ophthalmic implant

intravitreal injection of ozurdex implant

Trial Locations (1)

Unknown

INMC, Abu Dhabi

All Listed Sponsors
lead

Benha University

OTHER

NCT03971279 - Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis | Biotech Hunter | Biotech Hunter